Long‑term safety of IMA203 and IMA203CD8 autologous T‑cell therapy in patients with previously treated advanced or metastatic solid tumors
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Safety and tolerability of OV329 as add‑on therapy in adults with drug‑resistant focal epilepsy
Not yet recruiting
Investigated Diseases:
Phase 3 study of mitapivat for effectiveness and safety in children with non‑transfusion‑dependent alpha or beta thalassemia
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Fosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older
Not yet recruiting
Investigated Diseases:Investigated Drugs:
powered by
